Clinical Utility of Deep Learning-based Multiple Arterial Phase MRI in Hepatocellular Carcinoma.

IF 7.2 Q1 ONCOLOGY
Kai Liu, Beixuan Zheng, Yunfei Zhang, Bin Wang, Jun Yang, Lu Wang, Mengsu Zeng, Ruofan Sheng
{"title":"Clinical Utility of Deep Learning-based Multiple Arterial Phase MRI in Hepatocellular Carcinoma.","authors":"Kai Liu, Beixuan Zheng, Yunfei Zhang, Bin Wang, Jun Yang, Lu Wang, Mengsu Zeng, Ruofan Sheng","doi":"10.1148/rycan.250538","DOIUrl":null,"url":null,"abstract":"<p><p>Purpose To evaluate the clinical utility of deep learning-based ultrafast multiple arterial phase (AP) MRI for diagnosing hepatocellular carcinoma (HCC), compared with conventional single AP imaging, using both extracellular agents (ECAs) and hepatobiliary agents (HBAs). Materials and Methods This prospective study included participants with suspected HCC who underwent either ECA- or HBA-enhanced MRI between September 2024 and March 2025. Outcomes included late AP capture rate, image quality (overall quality, motion artifacts, noise, liver and lesion edge sharpness, and lesion conspicuity), diagnostic performance (lesion, arterial phase hyperenhancement [APHE], and HCC detection rates), and hepatic arterial visualization scoring. Wilcoxon rank sum, Pearson χ<sup>2</sup>, and Fisher exact tests compared characteristics from multiple and single AP MRI. Results The final analysis included 128 participants who underwent ECA-enhanced MRI (64 multiphase, 64 single-phase; median age, 61 years [IQR, 54-69 years]; 103 male) and 108 participants who underwent HBA-enhanced MRI (54 multiphase, 54 single-phase; median age, 62 years [IQR, 56-69 years]; 83 male). In the ECA group, multiple AP MRI resulted in greater late AP capture (98% vs 81%; <i>P</i> = .001); higher scores for overall image quality (<i>P</i> = .03), motion artifacts (<i>P</i> < .001), lesion edge sharpness (<i>P</i> < .001), and lesion conspicuity (<i>P</i> = .007); and higher lesion (98% vs 90%; <i>P</i> = .01), APHE (96% vs 88%; <i>P</i> = .03), and HCC (96% vs 81%; <i>P</i> < .001) detection rates. In the HBA group, multiple AP MRI examinations also resulted in greater late AP capture (98% vs 85%; <i>P</i> = .04); higher scores for overall image quality (<i>P</i> = .01), motion artifacts (<i>P</i> = .04), and lesion edge sharpness (<i>P</i> = .005); and higher lesion (97% vs 88%; <i>P</i> = .04) and APHE (97% vs 86%; <i>P</i> = .02) detection rates. Multiphase imaging consistently achieved satisfactory hepatic arterial visualization in both contrast agent groups (mean scores > 3 on a four-point Likert scale for all categories). Conclusion Deep learning-based ultrafast multiphase arterial MRI improved late AP capture, image quality, and HCC diagnosis and enabled reliable hepatic arterial visualization within a single scan compatible with ECA and HBA. <b>Keywords:</b> MR-Imaging, Abdomen/GI, Liver <i>Supplemental material is available for this article.</i> © RSNA, 2026.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"8 2","pages":"e250538"},"PeriodicalIF":7.2000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13036681/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology. Imaging cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1148/rycan.250538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose To evaluate the clinical utility of deep learning-based ultrafast multiple arterial phase (AP) MRI for diagnosing hepatocellular carcinoma (HCC), compared with conventional single AP imaging, using both extracellular agents (ECAs) and hepatobiliary agents (HBAs). Materials and Methods This prospective study included participants with suspected HCC who underwent either ECA- or HBA-enhanced MRI between September 2024 and March 2025. Outcomes included late AP capture rate, image quality (overall quality, motion artifacts, noise, liver and lesion edge sharpness, and lesion conspicuity), diagnostic performance (lesion, arterial phase hyperenhancement [APHE], and HCC detection rates), and hepatic arterial visualization scoring. Wilcoxon rank sum, Pearson χ2, and Fisher exact tests compared characteristics from multiple and single AP MRI. Results The final analysis included 128 participants who underwent ECA-enhanced MRI (64 multiphase, 64 single-phase; median age, 61 years [IQR, 54-69 years]; 103 male) and 108 participants who underwent HBA-enhanced MRI (54 multiphase, 54 single-phase; median age, 62 years [IQR, 56-69 years]; 83 male). In the ECA group, multiple AP MRI resulted in greater late AP capture (98% vs 81%; P = .001); higher scores for overall image quality (P = .03), motion artifacts (P < .001), lesion edge sharpness (P < .001), and lesion conspicuity (P = .007); and higher lesion (98% vs 90%; P = .01), APHE (96% vs 88%; P = .03), and HCC (96% vs 81%; P < .001) detection rates. In the HBA group, multiple AP MRI examinations also resulted in greater late AP capture (98% vs 85%; P = .04); higher scores for overall image quality (P = .01), motion artifacts (P = .04), and lesion edge sharpness (P = .005); and higher lesion (97% vs 88%; P = .04) and APHE (97% vs 86%; P = .02) detection rates. Multiphase imaging consistently achieved satisfactory hepatic arterial visualization in both contrast agent groups (mean scores > 3 on a four-point Likert scale for all categories). Conclusion Deep learning-based ultrafast multiphase arterial MRI improved late AP capture, image quality, and HCC diagnosis and enabled reliable hepatic arterial visualization within a single scan compatible with ECA and HBA. Keywords: MR-Imaging, Abdomen/GI, Liver Supplemental material is available for this article. © RSNA, 2026.

基于深度学习的肝细胞癌多动脉期MRI的临床应用
目的评价基于深度学习的超快多动脉期(AP) MRI在诊断肝细胞癌(HCC)中的临床应用,并与传统的单次AP成像(同时使用细胞外药物(ECAs)和肝胆药物(HBAs))进行比较。材料和方法本前瞻性研究纳入了2024年9月至2025年3月期间接受ECA或hb增强MRI检查的疑似HCC患者。结果包括晚期AP捕获率、图像质量(总体质量、运动伪影、噪声、肝脏和病变边缘清晰度、病变显著性)、诊断性能(病变、动脉期高增强[APHE]和HCC检出率)和肝动脉可视化评分。Wilcoxon秩和、Pearson χ2和Fisher精确检验比较了多个和单个AP MRI的特征。结果最终分析包括128名接受eca增强MRI的参与者(64名多相期,64名单相期;中位年龄61岁[IQR, 54-69岁];103名男性)和108名接受hb增强MRI的参与者(54名多相期,54名单相期;中位年龄62岁[IQR, 56-69岁];83名男性)。在ECA组中,多次AP MRI导致更大的晚期AP捕获(98%对81%,P = 0.001);整体图像质量(P = .03)、运动伪影(P < .001)、病变边缘清晰度(P < .001)和病变显著性(P = .007)得分较高;病变检出率(98%比90%,P = 0.01)、APHE检出率(96%比88%,P = 0.03)、HCC检出率(96%比81%,P < 0.001)较高。在HBA组中,多次AP MRI检查也导致更大的晚期AP捕获(98% vs 85%; P = .04);在整体图像质量(P = 0.01)、运动伪影(P = 0.04)和病变边缘清晰度(P = 0.005)方面得分较高;病变检出率(97%对88%,P = .04)和APHE检出率(97%对86%,P = .02)较高。在两种造影剂组中,多相显像均获得了令人满意的肝动脉显像(所有类别的4分李克特量表平均得分为>.3)。结论基于深度学习的超快多相动脉MRI改善了晚期AP捕获、图像质量和HCC诊断,并在与ECA和HBA兼容的单次扫描中实现了可靠的肝动脉可视化。关键词:磁共振成像,腹部/胃肠道,肝脏,本文有补充材料。©rsna, 2026。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
2.30%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书